rs77121899

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_182961.4(SYNE1):​c.8336T>G​(p.Ile2779Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0026 in 1,614,084 control chromosomes in the GnomAD database, including 108 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 54 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 54 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

2
5
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 7.15
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00431782).
BP6
Variant 6-152387223-A-C is Benign according to our data. Variant chr6-152387223-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 130451.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152387223-A-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0144 (2199/152208) while in subpopulation AFR AF= 0.0506 (2102/41508). AF 95% confidence interval is 0.0488. There are 54 homozygotes in gnomad4. There are 1047 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2199 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE1NM_182961.4 linkc.8336T>G p.Ile2779Ser missense_variant Exon 54 of 146 ENST00000367255.10 NP_892006.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkc.8336T>G p.Ile2779Ser missense_variant Exon 54 of 146 1 NM_182961.4 ENSP00000356224.5 Q8NF91-1
SYNE1ENST00000423061.6 linkc.8357T>G p.Ile2786Ser missense_variant Exon 54 of 146 1 ENSP00000396024.1 A0A0C4DG40
SYNE1ENST00000461872.6 linkn.8554T>G non_coding_transcript_exon_variant Exon 52 of 55 1

Frequencies

GnomAD3 genomes
AF:
0.0144
AC:
2197
AN:
152090
Hom.:
54
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00465
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.0100
GnomAD3 exomes
AF:
0.00371
AC:
933
AN:
251236
Hom.:
21
AF XY:
0.00292
AC XY:
397
AN XY:
135776
show subpopulations
Gnomad AFR exome
AF:
0.0517
Gnomad AMR exome
AF:
0.00226
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000705
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00137
AC:
1997
AN:
1461876
Hom.:
54
Cov.:
32
AF XY:
0.00120
AC XY:
871
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.0500
Gnomad4 AMR exome
AF:
0.00226
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000315
Gnomad4 OTH exome
AF:
0.00283
GnomAD4 genome
AF:
0.0144
AC:
2199
AN:
152208
Hom.:
54
Cov.:
32
AF XY:
0.0141
AC XY:
1047
AN XY:
74424
show subpopulations
Gnomad4 AFR
AF:
0.0506
Gnomad4 AMR
AF:
0.00465
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00994
Alfa
AF:
0.00231
Hom.:
7
Bravo
AF:
0.0162
ESP6500AA
AF:
0.0540
AC:
238
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00488
AC:
593
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Dec 12, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 19, 2024
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 23, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autosomal recessive ataxia, Beauce type Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant;C5193121:Arthrogryposis multiplex congenita 3, myogenic type Benign:1
Nov 18, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
18
DANN
Benign
0.90
DEOGEN2
Uncertain
0.57
D;.;T
Eigen
Benign
0.078
Eigen_PC
Benign
0.060
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
D;D;D
MetaRNN
Benign
0.0043
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.5
M;.;.
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-3.0
D;.;D
REVEL
Benign
0.16
Sift
Uncertain
0.0040
D;.;D
Sift4G
Pathogenic
0.0010
D;D;D
Polyphen
0.55
P;.;.
Vest4
0.77
MVP
0.63
MPC
0.42
ClinPred
0.043
T
GERP RS
4.5
Varity_R
0.37
gMVP
0.38

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77121899; hg19: chr6-152708358; API